Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-07-08

FDA Approved: LAMOTRIGINE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for Lamotrigine by Aurobindo Pharma Limited, enabling a generic lamotrigine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamotrigine (lamotrigine)

Snippet

SUPPL AP for LAMOTRIGINE (LAMOTRIGINE)